Skip to main content

and
  1. No Access

    Article

    Efficacy and safety of tirzepatide for treatment of overweight or obesity. A systematic review and meta-analysis

    Recent studies suggest that tirzepatide, a dual glucose-dependent insulinotropic-peptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA), has significant weight loss effects. This systematic revi...

    Bryan Tan, **n-Hui Pan, Han Shi Jocelyn Chew in International Journal of Obesity (2023)